197
Views
20
CrossRef citations to date
0
Altmetric
Review

Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics

Pages 25-38 | Published online: 02 Mar 2005

Bibliography

  • RAJARATNAM SM, ARENDT J: Health in a 24-h society. Lancet (2001) 358:999–1005.
  • DUNCAN WC: Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther. (1996) 71:253–312.
  • ••A particularly thorough review, in particular with respect to the actions of antidepressant drugs.
  • BUNNEY WE, BUNNEY BG: Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology(2000) 22:335–345.
  • ••Captures well the potential link between themolecular oscillator and psychiatric disorders.
  • RUSAK B, ZUCKER I: Neural regulation of circadian rhythms. Physiol Rev. (1979) 59:449–526.
  • TUREK FW: Circadian neural rhythms in mammals. Annu. Rev. Physiol (1986) 47:49–64.
  • MOGA MM, MOORE RY: Organization of neural inputs to the suprachiasmatic nucleus in the rat. J. Comp. Nemo] (1997) 389:508–534.
  • MOORE RY, SPEH JC, LEAK RK: Suprachiasmatic nucleus organization. Cell Tissue Res. (2002) 309:89–98.
  • ••An excellent up-to-date resource forSCN neuroanatomy.
  • PROSSER RA: Serotonergic actions and interactions on the SCN circadian pacemaker: M vitro investigations. Biol. Rhythm Res. (2000) 3:315–339.
  • ••This paper and all those in this issue arehighly valuable summaries of the actions of monoarnines and clock function.
  • HASTINGS MH, DUFFIELD GE, SMITH EJ, MYWOOD ES, EBLING FJ: Entrainment of the circadian system of mammals by nonphotic cues. Chronobiol Int. (1998) 15:425–445.
  • MILLER JD, MORIN LP, SCHWARTZ WJ, MOORE RY: New insights into the mammalian circadian clock. Sleep (1996) 19:641–667.
  • MEYER-BERNSTEIN EL, MORIN LP: Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J.Neurosci. (1996) 16:2097–2111.
  • MORIN LP: Serotonin and the regulation of mammalian circadian rhythmicity. Ann. Med. (1999) 31:12–33.
  • CARD JP, MOORE RY: Organization of lateral geniculate-hypothalamic connections in the rat.' Comp. Neurol (1989) 284:135–147.
  • MORIN LP, BLANCHARD J, MOORE RY: Intergeniculate leaflet and suprachiasmatic nucleus organization and connections in the golden hamster. Vis. Neurosci. (1992) 8:219–230.
  • CZEISLER CA, DUFFY JF, SHANAHAN TL et al.: Stability, precision, and near 24-hour period of the human circadian pacemaker. Science (1999) 284:2177–2181.
  • WEHR TA, WIRZ-JUSTICE A, GOODWIN FK, DUNCAN W, GILLIN JC: Phase advance of the circadian sleep-wake cycle as an antidepressant. Science (1979) 206:710–713.
  • ••Landmark publication describing the firstinstance of antidepressant efficacy through phase adjustment.
  • WEHR TA, SACK D, ROSENTHAL N, DUNCAN W, GILLIN JC: Circadian rhythm disturbances in manic-depressive illness. Fed. Proc. (1983) 42:2809–2814.
  • BENCA RIVI, OBERMEYER WH, THISTED RA, GILLIN JC: Sleep and psychiatric disorders. A meta-analysis. Arch. Gen. Psychiatry(1992) 49:651–668.
  • WEHR TA, MUSCETTOLA G, GOODWIN FK: Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase advance) in manic-depressives compared with normal subjects. Arch. Gen. Psychiatry (1980) 37:257–263.
  • WEHR TA, WIRZ-JUSTICE A: Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatry (1982) 15:31–39.
  • GILLIN JC, DUNCAN W, PETTIGREW BL, FRANKEL F, SNYDER F: Successful separation of depressed, normal and insomniac subjects by sleep EEG data. Arch. Gen. Psychiatry (1979) 36:85–90.
  • SACK DA, NURNBERGER J, ROSENTHAL NE, ASHBURN E, WEHR TA: Potentiation of antidepressant medications by phase advance of the sleep-wake cycle. Am. Psychiatry (1985) 142:606-608. WIRZ-JUSTICE A, VAN DEN HOOFDAKKER R: Sleep deprivation in depression: what do we know, where do we go? Biol. Psychiatry (1999) 46:445-453. Thoughtful review of the topic.
  • BICAKOVA-ROCHER A, GORCEIX A,REINBERG A, ASHKENAZI II, TICHER A: Temperature rhythm of patients with major affective disorders: reduced circadian period length. Chronobiol mt. (1996) 13:47–57.
  • WEHR TA, SACK DA, DUNCAN WC, MENDELSON WB, ROSENTHAL NE, GILLIN JC: Sleep and circadian rhythms in affective patients isolated from external time cues. Psychiatry Res. (1985) 15:327–339.
  • KOORENGEVEL KM, BEERSMA DG, GORDIJN MC, DEN BOER JA, VAN DEN HOOFDAKKER RH: Body temperature and mood variations during forced desynchronization in winter depression: a preliminary report. Biol. Psychiatry (2000) 47:355–358.
  • WIRZ-JUSTICE A, CAJOCHEN C, NUSSBAUM P: A schizophrenic patient with an arrhythmic circadian rest-activity cycle. Psychiatry Res. (1997) 73:83–90.
  • OHASHI Y, OKAMOTO N, UCHIDA K, IYO M, MORI N, MORITA Y: Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. Biol. Psychiatry (1999) 45:1646–1652.
  • CERMAKIAN N, BOIVIN D: A molecular perspective of human circadian disorders. Brain Res. Rev (2003) 42:204–220.
  • ••Detailed and comprehensive review.
  • MONK TH: What can the chronobiologistdo to help the shift worker? j. Biol. Rhythms (2000) 15:86–94.
  • JONES CR, CAMPBELL SS, ZONE SE et al.: Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat. Neurosci. (1999) 5:1062–1065.
  • •Highly interesting reading.
  • VAN ESSEVELDT LE, HEHMAN MN, BOER GJ: The suprachiasmatic nucleus and the circadian timing system revisited. Bich) Res. Rev (2000) 33:34–77.
  • MOORE RY, SPEH JC: GABA is the principle neurotransmitter of the circadian system. Neurosci. Lett. (1993) 150:112–116.
  • SHINOHARA K, HONMA S, KATSUNO Y, ABE H, HONMA K: Two distinct oscillators in the rat suprachiasmatic nucleus IP vitro. Proc. Nati Acad. ScL USA (1995) 92:7396–7400.
  • WELSH DK, LOGOTHETIS DE, MEISTER M, REPPERT SM: Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron (1995) 14:697–706.
  • LIU C, WEAVER DR, STROGATZ SH, REPPERT AM: Cellular construction of a circadian clock: period determination in the suprachiasmatic nuclei. Cell (1997) 91:855–860.
  • QUINTERO JE, KUHLMAN SJ, MCMAHON DG: The biological clock nucleus: a multiphasic oscillator network regulated by light. J. Neurosci. (2003) 23:8070–8076.
  • HONMA S, SHIRAKAWA W, NAKAMURA W, HONMA K: Synaptic communication of cellular oscillations in the rat suprachiasmatic neurons. Neurosci. Lett. (2000) 294:113–116.
  • SHINOHARA K, HIRUMA H, FUNABASHI T, KIMURA F: GABAergic modulation of gap junction communication in slice cultures of the rat suprachiasmatic nucleus. Neuroscience (2000) 96:591–596.
  • SHIRAKAWA T, HONMA S, HONMA K: Multiple oscillators in the suprachiasmatic nucleus. Chronobiol Int. (2001) 18:371–387.
  • SILVER R, LESAUTER J, TRESCO PA, LEHMAN MN: A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature (1996) 382:810–813.
  • CUTLER DJ, HARAURA M, REED HE et al.: The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide M vitro. Eur. Neurosci. (2003) 17:197–204.
  • •Along with [43] below, this review makes a compelling case for the role of VIP.
  • HAMAR AJ, MARSTON HM, SHEN S et al.: The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell (2002) 109:497–508.
  • KONOPKA RJ, BENZER S: Clock mutants of Drosophila melanogaster. Proc. Nati Acad. Sci. USA (1971) 68:2112–2116.
  • FELDMAN JF, HOYLE MN: Isolation of circadian clock mutants of Neurospora crassa. Genetics (1973) 75:605–613.
  • GEKAKIS N, STAKNIS D, NGUYEN HB et al.: Role of the CLOCK protein in the mammalian circadian mechanism. Science (1998) 280:1564–1569.
  • TRAVNICKOVA-BENDOVA Z, CERMAKIAN N, REPPERT SM, SASSONE-CORSI P: Bimodal regulation of mPeriod promoters by CREB-dependent signalling and CLOCK/BMAL1 activity. Proc. Natl Acad. ScL USA (2002) 99:7728–7733.
  • YAMAGUCHI S, MITSUI S, MIYAKE S et al.: The 5" upstream region of mPerl gene contains two promotors and is responsible for circadian oscillation. Curr. Biol. (2000) 10:873–876.
  • GRIFFIN EA, STAKNIS D, WEITZ CJ: Light-independent role of CRY1 and CRY2 in the mammalian circadian clock. Science (1999) 286:768–771.
  • KUME K, ZYLKA MJ, SRIAM S et al: mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell (1999) 98:193–205.
  • ONISHI H, YAMAGUCHI S, YAGITA K et al.: Rev-erba gene expression in the mouse brain with special emphasis on its circadian profiles in the suprachiasmatic nucleus. Neurosci. Res. (2002) 68:551–557.
  • PREITNER N, DAMIOLA F, LOPEZ-MOLINA L et al: The orphan nuclear receptor REV-ERBa controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell (2002) 110:251–260.
  • UEDA HR, CHEN W, ADACHI A et al:A transcription factor response element for gene expression during circadian night. Nature (2002) 418:534–539.
  • SHEARMAN LP, SRIAM S, WEAVER DR et al.: Interacting molecular loops in the mammalian circadian clock. Science (2000) 288:1013–1019.
  • CERMAKIAN N, MONACO L, PANDO MP, DIERICH A, SASSONE-CORSI P: Altered behavioural rhythms and clock gene expression in mice with a targeted mutation in the Periodl gene. EMBO (2001) 20:3967–3974.
  • LOWREY PL, SHIMIMURA K, ANTOCH MP et al.: Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science (2000) 288:483–492.
  • •Interesting reading for a perspective on casein kinase inhibitors.
  • VITATERNA MH, KING DP, CHANG AM et al.: Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behaviour. Science (1994) 264:719–725.
  • •Early report on the importance of clock gene function.
  • JINX, SHEARMAN LP, WEAVER DR, ZYLKA MJ, DEVRIES GJ, REPPERT SM: A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell (1999) 96:57–68.
  • RIPPERGER JA, SHEARMAN LP, REPPERT SM, SCHIBBLER U: CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes Dev. (2000) 14:679–689.
  • LEE C, ETCHEGARAY JP, CAGAMPANG FR, LOUD ON AS, REPPERT SM: Posttranslational mechanisms regulate the mammalian circadian clock. Cell (2001) 107:855–867.
  • VIELHABER E, EIDE E, RIVERS A, GAO ZH, VIRSHUP DM: Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I E. Ma Cell. Biol. (2000) 20:4888–4899.
  • YAGITA K, TAMANINI F, YASUDA M, HOEIJMAKERS JH, VAN DER HORST GT, OKAMURA H: Nucleocytoplasmic shuttling and mCRY-dependent inhibition of ubiquitylation of the mPER2 clock protein. EMBO (2002) 21:1301–1314.
  • EIDE EJ, VIELHABER EL, HINZ WA, VIRSHUP DM: The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase I E. J. Biol. Chem. (2002) 277:17248–17254.
  • KEESLER GA, CAMACHO F, GUO Y, VIRSHUP D, MONDADORI C, YAO Z: Phosphorylation and destabilization of human period 1 clock protein by human casein kinase I E. Neuroreport (2000) 119:1220–1223.
  • AKASHI M, TSUCHIYA Y, YOSHINO T, NISHIDA E: Control of intracellular dynamics of mammalian period proteins by casein kinase I E (CKIE) and CKIS in cultured cells. MM. Cell. Biol. (2002) 22:1693–1703.
  • DUNLAP JC: Molecular basis for circadianclocks. Cell (1999) 290:271–290.
  • EIDE EJ, VIELHABER EL, HINZ WA, VIRSHUP DM: The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase IE. Biol. Chem. (2002) 277:17248–17254.
  • DINGY, DALE T: Wnt signal transduction:kinase cogs in a nano-machine? Trends Biochem. Sci. (2002) 27:327–329.
  • MARTINEK S, INONOG S, MANOUKIAN AS, YOUNG MW: A role for the segment polarity gene shaggy/ CSK-3 in the Drosophila circadian clock. Cell (2001) 105:769–779.
  • MOORE RY, LENN NJ: A retinohypothalamic projection in the rat. J. Comp. Neurol (1972) 146:1–14.
  • BERSON DM, DUNN FA, TAKAO M: Phototransduction by retinal ganglion cells that set the circadian clock. Science (2002) 295:1070–1073.
  • ••Along with [72-74], this reviewdistinguishes visual photoreception from circadian photoreception.
  • HATTAR S, LIAO HW, TAKAO M, BERSON DM, YAU KM: Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science (2002) 295:1065–1070.
  • PANDA S, SATO TK, CASTRUCCI AM et al.: Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science (2002) 298:2213–2216.
  • RUBY NF, BRENNAN TJ, XIE X et al.: Role of melanopsin in circadian responses to light. Science (2002) 298:2211–2213.
  • SELBY CP, THOMPSON C, SCHMITZ TM, VAN GELDER RN: Functional redundancy of cryptochromes and classical photoreceptors for nonvisual ocular photoreceptors in mice. Proc. Natl. Acad. Sci. USA (2000) 97:14697–14702.
  • CERMAKIAN N, SASSONE-CORSI P: Environmental stimulus perception and control of circadian clocks. Curr. Opin. Neurobiol (2002) 12:359–365.
  • EBLING FJ: The role of glutamate in thephotic regulation of the suprachiasmatic nucleus. Frog. Neurobiol (1996) 50:109–132.
  • KORNHAUSER JM, GINTY DD, GREENBERG ME, MAYO KE, TAKAHASHI JS: Light entrainment and activation of signal transduction pathways in the SCN. Frog. Brain Res. (1996) 111:133–145.
  • MINTZ EM, MARVEL CL, GILLESPIE CF, PRICE KM, ALBERS HE: Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo. NeuroscL (1999) 19:5124–5130.
  • DING JM, CHEN D, WEBER ET, FAIMAN LE, REA MA, GILLETTE MU: Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science (1994) 266:1713–1717.
  • PROSSER RA: Glutamate blocks serotonergic phase advances of the mammalian circadian pacemaker through AMPA and NMDA receptors. NeuroscL (2001) 21:7815–7822.
  • HANNIBAL J, DING JM, CHEN D, FAHRENKRUG J, LARSEN PJ, GILLETTE MU: Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. NeuroscL (1997) 17:2637–2644.
  • HARRINGTON ME, HOQUE S, HALL A, GOLOMBEK D, BIELLO S: Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light. J. Neurosci. (1999) 19:6637–6642.
  • SHIBATA S, TSUNEYOSHI A, HAMADA T, TOMINAGA K, WATANABE S: Effect of substance P on circadian rhythms of firing activity and the 2-dexoyglucose uptake in the rat suprachiasmatic nucleus M vitro. Brain Res. (1992) 597:257–263.
  • SHIRAKAWA T, MOORE RY: Responses of rat suprachiasmatic nucleus neurons to substance P and glutamate M vitro. Brain Res. (1994) 642:213–220.
  • CHALLET E, NAYLOR E, METZGER JM, MACINTYRE DE, TUREK FW: An NKI receptor antagonist affects the circadian regulation of locomotor activity in golden hamsters. Brain Res. (1998) 800:32–39.
  • CHALLET E, DUGOVIC C, TUREK FVV, VAN REETH O: The selective neuroldnin 1 receptor antagonist R116301 modulates photic responses of the hamster circadian system. Neuropharmacology (2001) 40:408–415.
  • MORIN LP: The circadian visual system. Brant Res. Rev (1994) 67:102–127.
  • RUSAK B, MEIJER JH, HARRINGTON ME: Hamster circadian rhythms are phase-shifted by electrical stimulation of the geniculo-hypothalamic tract. Brain Res. (1989) 493:283–291.
  • BIELLO SM, GOLOMBEK A, HARRINGTON ME: Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus M vitro. Neuroscience (1997) 77:1049–1057.
  • HUHMAN KL, GILLESPIE CE MARVEL CL, ALBERS HE: Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor. Neumreport (1996) 7:1249–1252.
  • BIELLO SM, JANIK D, MROSOVSKY NM: Neuropeptide Y and behaviorally induced phase shifts. Neuroscience (1994) 62:273–279.
  • HARRINGTON ME, NANCE DM, RUSACK B: Double-labeling of neuropeptide Y-immunoreactive neurons which project from the geniculate to the suprachiasmatic nuclei. Brain Res. (1987) 410:275–282.
  • MORIN LP, BLANCHARD J, MOORE RY: Intergeniculate leaflet and suprachiasmatic nucleus organization and connections in the golden hamster. Vis. Neurosci. (1992) 8:219–230.
  • PROSSER RA: Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock M vitro. Brant Res. (1998) 808:31–41.
  • BIELLO SM: Enhanced photic phase shifting after treatment with antiserum to neuropeptide Y. Brain Res. (1995) 673:25–29.
  • BIELLO SM, MROVOSKY NM: Blocking the phase-shifting effect of neuropeptide Y with light. Proc. R. Soc. Lond. B. Biol. ScL (1995) 259:179–187.
  • WEBER ET, REA MA: Neuropeptide Y blocks light-induced phase advances but not delays of the circadian activity rhythm in hamsters. Neurosci. Lett. (1997) 231:159–162.
  • YANNIELLI PC, HARRINGTON ME: The neuropeptide Y Y5 receptor mediates the blockade of `photic-like' NMDA-induced phase shifts in the golden hamster. J. Neurosci. (2001) 21:5367–5373.
  • LALL GS, BIELLO SM: Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist. Neuroscience (2003) 119:611–618.
  • MOORE RY, HALARIS AE, JONES BE: Serotonin neurons of the midbrain raphe: ascending projections. Comp. Neurol (1978) 180:417–438.
  • VAN DER KAR LD, LORENS SA: Differential serotonergic innervation of hypothalamic nuclei and other forebrain regions by dorsal and median midbrain raphe nuclei. Brain Res. (1979) 162:45–54.
  • MEYER-BERNSTEIN EL, MORIN LP: Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. Neurosci. (1996) 16:2097–2111.
  • GLASS JD, NINARDO LA, EHLEN JC: Dorsal raphe nuclear stimulation of SCN serotonin release and circadian phase-setting. Brain Res. (2000) 859:224–232.
  • MORIYA T, YOSHINOBU Y, IKEDA M, YOKOTA S, AKIYAMA M, SHIBATA S: Potentiating action of MKC-242, a selective 5-HTIA receptor agonist, on the photic entrainment of the circadian activity rhythm in hamsters. Br. Pharmacol (1998) 125:1281–1287.
  • LOVENBERG TW, BARON BM, DE LECCA L et al.: A novel adenylate cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron (1993) 11:449–458.
  • •An early description of a new 5-HT receptor, which is noteworthy for its inclusion of in vivo data.
  • SMITH BN, SOLLARS PJ, DUDEK FE, PICKARD GE: Serotonerigc modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors. Biol. Rhythms (2001) 16:25–38.
  • SPROUSE JS, REYNOLDS L, LI X, BRASELTON JP, SCHMIDT A: 8-0H-DPAT as a 5-HT(7) agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology (2004) 46:52–62.
  • REA MA, PICKARD GE: Serotonergic modulation of photic entrainment in the syrian hamster. Biol. Rhythm Res. (2000) 31:284–314.
  • ••Another interesting article from an entireissue dedicated to monoarnines and clock function.
  • BONAVENTURE P, NEPOMUCENO D, KWOK A et al.: Reconsideration of 5-hydroxtryptamine (5-HT) (7) receptor distribution using [3H]5-carboxyamidotryptamine and [31-I]8-hydroxy 2 (di n propylamino)tetraline: analysis in brain of 5-HTIA knockout and 5-HTIA/1B double-knockout mice. Pharmacol Exp. Ther. (2002) 302:240–248.
  • EHLEN JC, GROSSMAN GH, GLASS JD: In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus. NeuroscL (2001) 21:5351–5357.
  • •Use of reverse microdialysis of drugs to mimic systemic dosing.
  • WEBER ET, GANNON RL, REA MA: Local administration of serotonin agonists blocks light-induced phase advances of the circadian activity rhythm in the hamster. Biol. Rhythms (1998) 13:209–218.
  • MINTZ EM, GILLESPIE CF, MARVEL CL, HUHMAN KL, ALBERS HE: Serotonergic regulation of circadian rhythms in syrian hamsters. Neuroscience (1997) 79:563–569.
  • GANNON RL: 5-HT7 receptors in the rodent suprachiasmatic nucleus. Biol. Rhythms (2001) 16:19–24.
  • CUTERA RA, SABOUREAU, PEVET P: Phase-shifting effect of 8-0H-DPAT, a 5-HTIA/5-HT7 receptor agonist, on locomotor activity in golden hamster in constant darkness. NeuroscL Lett. (1996) 210:1–4.
  • ANTLE MC, OGILVIE MD, PICKARD GE, MISTLBERGER RE: Response of the mouse circadian system to serotonin 1A/2/7 agonists in vivo: surprisingly little. Biol. Rhythms (2003) 18:145–158.
  • PROSSER RA: Serotonin phase-shifts the mouse suprachiasmatic circadian clock in vitro. Brain Res. (2003) 966:110–115.
  • PICKARD GE, WEBER ET, SCOTT PA, RIBERDY AF, REA MA: 5-HT1B receptor agonists inhibit light-induced phase shifts of behavioural circadian rhythms and expression of the intermediate-early gene c-fos in the suprachiasmatic nucleus. NeuroscL (1996) 16:8208–8220.
  • ••Along with [119], this review provides a compelling argument for the role of 5-HT1B heteroreceptors.
  • PICKARD GE, SMITH BN, BELENKY M, REA MA, DUDEK FE, SOLLARS PJ: 5-HT1B receptor-mediated presynaptic inhibition of retinal input to the suprachiasmatic nucleus. Neurosci. (1999) 19:4034–4045.
  • SPROUSE JS, REYNOLDS L, BRASELTON J, SCHMIDT A: Does serotonin produce phase advances of SCN neuronal firing through activation of 5-HT5A receptors? Abstr. Soc. Neurosci (2002).
  • DUNCAN MJ, JENNES L, JEFFERSON JB, BROWNFIELD MS: Localisation of serotonin5A receptors in discrete regions of the circadian timing system in the syrian hamster. Brain Res. (2000) 869:175–185.
  • OLIVER KR, KINSLEY AM, WAINWRIGHT A, SIRINATHSINGHJI DJS: Localisation of 5-HT5A receptor-like immunoreactivity in the rat brain. Brain Res. (2000) 867:131–142.
  • BELENKY MA, PICKARD GE: Subcellular distribution of 5-HT1B and 5-HT7 receptors in the mouse suprachiasmatic nucleus. Comp. Nemo]. (2001) 432:381–388.
  • YANNIELLI PC, CADEIRAS M, GREGORETTI L, KARGIEMAN L, CARDINALI DP, GOLOMBEK DA: Effects of clomipramine administration on syrian hamster circadian system and behaviour. Biol. Rhythm Res. (2000) 31:391–415.
  • ••Another interesting article from anentire issue dedicated to monoamines and clock function.
  • LAM RW, ZIS AO, GREWAL A, DELGADO PL, CHARNEY DS, KRYSTAL JH: Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch. Gen. Psychiatry (1996) 53:41–44.
  • DELAGRANGE P, ATKINSON J, BOUTIN JA et al.: Therapeutic perspectives for melatonin agonists and antagonists.' Neuroendocrinol (2003) 15:442–448.
  • CAJOCHEN C, KRAUCHI K, WIRZ-JUSTICE A: Role of melatonin in the regulation of human circadian rhythms and sleep. Neuroendocrinol (2003) 15:432–437.
  • MOORE RY, KLEIN DC: Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase. Brain Res. (1974) 71:17–33.
  • REPPERT SM, PERLOW MJ, UNGERLEIDER LG et al.: Effects of damage to the suprachiasmatic area of anterior hypothalamus on the daily melatonin and cortisol rhythms in the rhesus monkey. J. Neurosci. (1981) 1:1414–1425.
  • PAPP M, GRUCA P, BOYER PA, MOCAER E: Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychophannacology (2003) 28:694–703.
  • •A difference in timed administration of agomelatine may signal different effector pathways.
  • MILES A, PHILBRICK DR: Melatonin and psychiatry. Biol. Psychiatry(1988) 23:405–425.
  • ABRAHAMSON EE, LEAK RK, MOORE RY: The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport (2001) 22:350–356.
  • ASTON-JONES G, CHEN S, ZHU Y, OSHINSKY ML: A neural circuit for circadian regulation of arousal. Nat. Neurosci. (2001) 4:732–738.
  • BUIJS RM, LA FLEUR SE, WORTEL J et al.: The suprachiasmatic nucleus balances sympathetic and parasympathetic output to peripheral organs through separate preautonomic neurons. Comp. Neural. (2003) 464:36–48.
  • ZYLKA MJ, SHEARMAN LP, WEAVER DR, REPPERT SM: Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron (1998) 20:1103–1110.
  • ONISHI K, SAKAMOTO K, OKADA T, NAGASE T, ISHIDA N: Antiphase circadian expression between BMAL1 and period homologue mRNA in the suprachiasmatic nucleus and peripheral tissues of rats. Biochem. Biophys. Res. Commun. (1998) 253:199–203.
  • TOSINI G, MENAKER M: Circadian rhythms in cultured mammalian retina. Science (1996) 272:419–421.
  • REICK M, GARCIA JA, DUDLEY C, MCKNIGHT SL: NPAS2: an analog of clock operative in mammalian forebrain. Science (2001) 293:506–509.
  • KALSBEEK A, VAN HEERIKHUIZE JJ, WORTEL J, BUIJS RIVI: A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. Neurosci. (1996) 16:5555–5565.
  • KRAMER A, WANG FC, SNODGRASS P et al.: Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signalling. Science (2001) 294:2511–2515.
  • CHENG MY, BULLOCK CM, LI C et al: Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature (2002) 417:405–410.
  • ••This might represent the key tounderstanding SCN output.
  • WAGNER S, CASTEL M, GAINER H, YAROM Y: GABA in the mammalian suprachiasmatic nucleus and its role in diurnal rhythmicity. Nature (1997) 387:598–603.
  • ELLIOTT KJ, WEBER ET, REA MA: Adenosine Al receptors regulate the response of the hamster circadian clock to light. Eur. Pharmacol (2001) 414:43–53.
  • JACOBS EH, YAMATODANI A, TIMMERMAN H: Is histamine the final neurotransmitter in the entrainment of circadian rhythms in mammals? Trends Pharmacol Sci. (2000) 21:293–298.
  • PIGGINS HD, ANTLE M, RUSAK B: Neuropeptides phase shift the mammalian circadian pacemaker. J. Neurosci. (1995) 15:5612–5622.
  • PITTENDRIGH CS: Circadian systems: entrainment. In: Handbook of Behavioural Neurobiology (Vol. 4). Biological Rhythms. AschoffJ (Ed.), Plenum Press, New York (1981):95–124. A classic for the chronobiologist.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.